Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies

Human Mutation

Volumn 13, Issue 1, 1999, Pages 11-28

  Nelis, Eva ^a   Haites, Neva ^b   Van Broeckhoven, Christine ^a,c  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

CMT; Cx32; DSS; HNPP; MPZ; PMP22

Indexed keywords

CONNEXIN 32; MEMBRANE PROTEIN; MYELIN PROTEIN; TRANSCRIPTION FACTOR;

CHROMOSOME 10Q; CHROMOSOME 17P; CHROMOSOME 1Q; CHROMOSOME XQ; GENE MUTATION; GENETIC DISORDER; GENOTYPE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MYELINATION; PERIPHERAL NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SCHWANN CELL;

CHARCOT-MARIE-TOOTH DISEASE; CONNEXINS; GENOTYPE; HEREDITARY MOTOR AND SENSORY NEUROPATHIES; HUMANS; IMMEDIATE-EARLY PROTEINS; MYELIN P0 PROTEIN; MYELIN PROTEINS; PHENOTYPE;

EID: 0032948117     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1004(1999)13:1<11::AID-HUMU2>3.0.CO;2-A     Document Type: Review

References (135)

1. Adlkofer K, Martini R, Aguzzi A, Zielasek J, Toyka KV, Suter U. 1995. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nature Genet 11:274-280.
2. Adlkofer K, Frei R, Neuberg DHH, Zielasek J, Toyka KV, Suter U. 1997. Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy. J Neurosci 17:4662-4671.
3. Anzini P, Neuberg DHH, Schachner M, Nelles E, Willecke K, Zielasek J, Toyka KV, Suter U, Martini R. 1997. Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32. J Neurosci 17:4545-4551.
4. 0 gene in a family with severe Charcot-Marie-Tooth disease. Hum Mutat 7:377-378.
5. Ben Othmane K, Middleton LT, Loprest LJ, Wilkinson KM, Lennon F, Rozear MP, Stajich JM, Gaskell PC, Rosed AD, Pericak-Vance MA, Vance JM. 1993. Localization of a gene (CMT2A) for autosomal dominant Charcot-Marie-Tooth disease type 2 to chromosome 1p and evidence of genetic heterogeneity. Genomics 17:370-375.
6. Bergoffen J, Scherer SS, Wang S, Oronzi Scott M, Bone LJ, Paul DL, Chen K, Lensch MW, Chance PF, Fischbeck KH. 1993. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 262:2039-2042.
7. Bird TD, Ott J, Giblett ER. 1982. Evidence for linkage of Charcot-Marie-Tooth neuropathy to the Duffy locus on chromosome 1. Am J Hum Genet 34:388-394.
8. Blanquet-Grossard F, Pham-Dinh D, Dautigny A, Latour P, Bonnebouche C, Corbillon E, Chazot G, Vandenberghe A. 1995. Charcot-Marie-Tooth type 1B neuropathy: third mutation at the serine 63 codon in the major peripheral myelin glycoprotein P0 gene. Clin Genet 48:281-283.
9. Blanquet-Grossard F, Pham-Dinh D, Dautigny A, Latour P, Bonnebouche C, Diraison P, Chapon F, Chazot G, Vandenberghe A. 1996. Charcot-Marie-Tooth type 1B neuropathy: a mutation at the single glycosylation site in the major peripheral myelin glycoprotein P0. Hum Mutat 8:185-186.
10. Bone LJ, Dahl N, Lensch MW, Chance PF, Kelly T, Le Guern E, Magi S, Parry G, Shapiro H, Wang S, Fischbeck KH. 1995. New connexin32 mutations associated with X-linked Charcot-Marie-Tooth disease. Neurology 45:1863-1866.
11. Bone LJ, Deschênes SM, Balice-Gordon RJ, Fischbeck KH, Scherer SS. 1997. Connexin32 and X-linked Charcot-Marie-Tooth disease. Neurobiol Disease 4:221-230.
12. Bort S, Nelis E, Timmerman V, Sevilla T, Cruz-Martinez A, Martinez F, Millan JM, Arpa J, Vilchez JJ, Prieto F, Van Broeckhoven C, Palau F. 1997. Mutation analysis of the MPZ, PMP22 and Cx32 genes in Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies patients with Spanish ancestry. Hum Genet 99:746-754.
13. Bort S, Sevilla T, Garcia-Planells J, Blesa D, Paricio N, Vilchez JJ, Prieto F, Palau F. 1998. Déjérine-Sottas neuropathy associated with de novo S79P mutation of the peripheral myelin protein 22 (PMP22) gene. Hum Mutat Suppl 1:S95-S98.
14. Bruzzone R, White TW, Scherer SS, Fischbeck KH, Paul DL. 1994. Null mutations of connexin32 in patients with X-linked Charcot-Marie-Tooth disease. Neuron 13:1253-1260.
15. Bruzzone R, White TW, Paul DL. 1996. Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem 233:1-27.
16. Chance PF, Matsunami N, Lensch MW, Smith B, Bird TD. 1992. Analysis of the DNA duplication 17p11.2 in Charcot-Marie-Tooth neuropathy type 1 pedigrees: additional evidence for a third autosomal CMT1 locus. Neurology 42:2037-2041.
17. Cherryson AK, Yeung L, Kennerson ML, Nicholson GA, 1994. Mutational studies in X-linked Charcot-Marie-Tooth disease (CMTX). Am J Hum Genet 55:216.
18. De Jonghe P, Timmerman V, Nelis E, Martin J-J, Van Broeckhoven C. 1997a. Charcot-Marie-Tooth disease and related peripheral neuropathies. J Peripheral Nervous System 2:370-387.
19. De Jonghe P, Timmerman V, FitzPatrick D, Spoelders P, Martin J-J, Van Broeckhoven C. 1997b. Mutilating neuropathic ulcerations in a chromosome 3q13-q22 linked Charcot-Marie-Tooth disease type 2B family. J Neurol Neurosurg Psychiatry 62: 570-573.
20. De Jonghe P, Timmerman V, Van Broeckhoven C, workshop participants. 1998. 2nd workshop of the European CMT consortium: 53rd ENMC international workshop on classification and diagnostic guidelines for Charcot-Marie-Tooth type 2 (CMT2 - HMSN II) and distal hereditary motor neuropathy (distal HMN - spinal CMT), 26-28 September 1997, Naarden - The Netherlands. Neuromuscular Disorders 8:426-431.
21. De Vos A, Sermon K, Van de Velde H, Joris H, Vandervorst M, Lissens W, Mortier G, De Sutter P, Löfgren A, Van Broeckhoven C, Liebaers I, Van Steirteghem A. Pregnancy after preimplantation genetic diagnosis for Charcot-Marie-Tooth disease type 1A, Molecular Human Reproduction in press.
22. Ding Y, Brunden KR. 1994. The cytoplasmic domain of myelin glycoprotein P0 interacts with the negatively charged phospholipid bilayers. J Biol Chem 269:10764-10770.
23. D'Urso D, Müller HW. 1997. Ins and outs of peripheral myelin protein-22: mapping transmembrane topology and intracellular sorting. J Neurosci Res 49:551-562.
24. Dyck PJ, Chance P, Lebo R, et al. 1993. Hereditary motor and sensory neuropathies. In: Dyck PJ, Thomas PK, Griffin JW, et al., editors. Peripheral neuropathy. Philadelphia: W.B. Saunders Company. p 1094-1136.
25. Dyck PJ, Litchy WJ, Minnerath S, Bird TD, Chance PF, Schiad DJ, Aronson AE. 1994. Hereditary motor and sensory neuropathy with diaphragm and vocal cord paresis. Ann Neurol 35:608-615.
26. Fairweather N, Bell C, Cochrane S, Chelly L, Wang S, Mostacciuolo ML, Monaco MP, Haites NE. 1994. Mutations in the connexin 32 gene in X-linked dominant Charcot-Marie-Tooth disease (CMTX1). Hum Mol Genet 3:29-31.
27. Gabern JG, Chen K, Kant J. 1996. Identification of a novel connexin 32 mutation associated with X-linked dominant Charcot-Marie-Tooth disease. Neurology 46:210.
28. Gabreëls-Festen AA, Bolhuis PA, Hoogendijk JE, Valentijn LJ, Eshuis EJ, Gabreëls FJ. 1995. Charcot-Marie-Tooth disease type 1A: morphological phenotype of the 17p duplication versus PMP22 point mutations. Acta Neuropathol Berl 90:645-649.
29. Gabreëls-Festen AAWM, Hoogendijk JE, Meijerink PHS, Gabreëls FJM, Bolhuis PA, van Beersum SEC, Kulkens T, Nelis E, Jennekens FGI, de Visser M, van Engelen BGM, Van Broeckhoven C, Mariman ECM. 1996. Two divergent types of nerve pathology in patients with different P0 mutations in Charcot-Marie-Tooth disease. Neurology 47:761-765.
30. Gal A, Mücke J, Theile H, Wieacker PF, Ropers HH, Wienker TF. 1985. X-linked dominant Charcot-Marie-Tooth disease: suggestion of linkage with a cloned DNA sequence from the proximal Xq. Hum Genet 70:38-42.
31. Giese KP, Martini R, Lemke G, Soriano P, Schachner M. 1992. Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin axons. Cell 71:565-576.
32. Gupta SK, Benstead T, Neumann P, Guernsey D. 1996. A point mutation in codon 3 of connexin-32 is associated with X-linked Charcot-Marie-Tooth neuropathy. Hum Mutat 8:375-376.
33. Haites NE, Nelis E, Van Broeckhoven C. 3rd workshop of the European CMT consortium: 54th ENMC international workshop on genotype-phenotype correlations in Charcot-Marie-Tooth type 1 and hereditary neuropathy with liability to pressure palsies, 28-30 November 1997, Naarden, The Netherlands. Neuromuscular Disorders, in press.
34. Hanemann CO, Stoll G, D'Urso M, Fricke W, Martin J-J, Van Broeckhoven C, Mancardi GL, Bartke I, Muller HW. 1994. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsy. J Neurosci Res 37:654-659.
35. Harding AE, Thomas PK. 1980. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103:259-280.
36. Hayasaka K, Himoro M, Wang Y, Takata M, Minoshima S, Shimizu N, Miura M, Uyemura K, Takada G. 1993a. Structure and chromosomal localization of the gene encoding the human myelin protein zero (MPZ). Genomics 17:755-758.
37. Hayasaka K, Himoro M, Sato W, Takada G, Uyemura K, Shimizu N, Bird T, Conneally PM, Chance PF. 1993b. Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene. Nature Genet 5:31-34.
38. Hayasaka K, Takada G, Ionasescu VV. 1993c. Mutation of the myelin P0 gene in Charcot-Marie-Tooth neuropathy type 1B. Hum Mo Genet 2:1369-1372.
39. Hayasaka K, Himoro M, Sawaishi Y, Nanao K, Takahashi T, Takada G, Nicholson GA, Ouvrier RA, Tachi N. 1993d. De novo mutation of the myelin P0 gene in Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). Nature Genet 5:266-268.
40. Hayasaka K, Ohnishi A, Takada G, Fukushima Y, Murai Y. 1993e. Mutation of the myelin P0 gene in Charcot-Marie-Tooth neuropathy type 1. Biochem Biophys Res Commun 194:1317-1322.
41. Himoro M, Yoshikawa H, Matsui T, Mitsui Y, Takahashi M, Kaido M, Nishimura T, Sawaishi Y, Takada G, Hayasaka K. 1993. New mutation of the myelin P0 gene in a pedigree of Charcot-Marie-Tooth neuropathy type 1. Biochem Mol Biol Int 31:169-173.
42. Huxley C, Passage E, Manson A, Putzu G, Figarella-Branger D, Pellissier JF, Fontés M. 1996. Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum Mol Genet 5:563-569.
43. Ikegami T, Nicholson G, Ikeda H, Ishida A, Johnston H, Wise G, Ouvrier R, Hayasaka K. 1996. A novel homozygous mutation of the myelin P0 gene producing Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). Biochem Biophys Res Commun 222:107-110.
44. Ikegami T, Ikeda H, Mitsui T, Hayasaka K, Ishii S. 1997. Novel mutation of the myelin P0 gene in a pedigree with Charcot-Marie-Tooth disease type 1B. Am J Med Genet 71:246-248.
45. Ikegami T, Ikeda H, Aoyama M, Matsuki T, Imota T, Fukuushi Y, Amano T, Toyoshima I, Ishihara Y, Endoh H, Hayasaka K. 1998a. Novel mutations of the peripheral myelin protein 22 gene in two pedigrees with Dejerine-Sottas disease. Hum Genet 102:294-298.
46. Ikegami T, Nicholson G, Ikeda H, Ishida A, Johnston H, Wise G, Ouvrier R, Hayasaka K. 1998b. De novo mutation of the myelin P0 gene in Déjérine-Sottas disease (hereditary motor and sensory neuropathy type III): two amino acid insertion after Asp 118. Hum Mutat Suppl 1:S103-S105.
47. Ionasescu VV, Ionasescu R, Searby C, Neahring R. 1995. Dejerine-Sottas disease with de novo dominant point mutation of the PMP22 gene. Neurology 45:1766-1767.
48. Ionasescu VV, Searby C, Sheffield VC, Roklina T, Nishimura D, Ionasescu R. 1996a. Autosomal dominant Charcot-Marie-Tooth axonal neuropathy mapped on chromosome 7p (CMT2D). Hum Mol Genet 5:1373-1375.
49. Ionasescu VV, Ionasescu R, Searby C. 1996b. Correlation between connexin 32 gene mutations and clinical phenotype in X-linked dominant Charcot-Marie-Tooth neuropathy. Am J Med Genet 63:486-491.
50. Ionasescu VV, Searby C, Ionasescu R, Neuhaus IM, Werner R. 1996c. Mutations of the noncoding region of the connexin32 gene in X-linked dominant Charcot-Marie-Tooth neuropathy. Neurology 47:541-544.
51. Ionasescu VV, Searby C, Greenberg SA. 1996d. Dejerine-Sottas disease with sensorineural hearing loss, nystagmus, and peripheral facial nerve weakness: De novo dominant point mutation of the PMP22 gene. J Med Genet 33:1048-1049.
52. Ionasescu VV, Searby CC, Ionasescu R, Chatkupt S, Patel N, Koenigsberger R. 1997a. Dejerine-Sottas neuropathy in mother and son with same point mutation of PMP22 gene. Muscle Nerve 20:97-99.
53. Ionasescu VV, Searby CC, Ionasescu R, Reisin R, Ruggieri V, Arberas C. 1997b. Severe Charcot-Marie-Tooth neuropathy type 1A with 1-base pair deletion and frameshift mutation in the peripheral myelin protein 22 gene. Muscle Nerve 20:1308-1310.
54. Janssen EAM, Kemp S, Hensels GW, Sie OG, de Die-Smulders CEM, Hoogendijk JE, de Visser M, Bolhuis PA. 1997. Connexin32 gene mutations in X-linked dominant Charcot-Marie-Tooth disease (CMTX1). Hum Genet 99:501-505.
55. Kulkens T, Bolhuis PA, Wolterman RA, Kemp S, te Nijenhuis S, Valentijn LJ, Hensels GW, Jennekens FGI, de Visser M, Hoogendijk JE, Baas F. 1993. Deletion of the serine 34 codon from the major peripheral myelin protein P0 gene in Charcot-Marie-Tooth disease type 1B. Nature Genet 5:35-39.
56. Kwon JM, Elliott JL, Yee WC, Ivanovich J, Scavarda NJ, Moolsintong PJ, Goodfellow PJ. 1995. Assignment of a second Charcot-Marie-Tooth type II locus to chromosome 3q. Am J Hum Genet 57:853-858.
57. Latour P, Blanquet F, Nelis E, Bonnebouche C, Chapon F, Diraison P, Ollagnon E, Dautigny A, Pham-Dinh D, Chazot G, Boucherat M, Van Broeckhoven C, Vandenberghe A. 1995. Mutations in the myelin protein zero gene associated with Charcot-Marie-Tooth disease type 1B. Hum Mutat 6:50-54.
58. Latour P, Fabreguette A, Ressot C, Blanquet-Grossard F, Antoine JC, Calvas P, Chapon F, Corbillon E, Ollagnon E, Sturtz F, Boucherat M, Chazot G, Dautigny A, Pham-Dinh D, Vandenberghe A. 1997a. New mutations in the X-linked form of Charcot-Marie-Tooth disease. Eur Neurol 37:38-42.
59. Latour P, Lévy N, Paret M, Chapon F, Chazot G, Clavelou P, Couratier P, Dumas R, Ollagnon E, Pouget J, Setiey A, Vallat J-M, Boucherat M, Fontes M, Vandenberghe A. 1997b Mutations in the X-linked form of Charcot-Marie-Tooth disease in the French population. Neurogenetics 1:117-123.
60. Lemke G. 1988. Unwrapping the genes for myelin. Neuron 1:535-543.
61. Lupski JR, Montes de Oca-Luna R, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, Saucedo-Cardenas O, Barker DF, Killian JM, Garcia CA, Chakravarti A, Patel PI. 1991. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66:219-239.
62. Magyar JP, Martini R, Ruelicke T, Aguzzi A, Adlkofer K, Dembic Z, Zielasek J, Toyka KV, Suter U. 1996. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J Neurosci 16:5351-5360.
63. Mariman ECM, Gabreëls-Festen AAWM, van Beersum SEC, Jongen PJH, van de Looij E, Baas F, Bolhuis PA, Ropers HH, Gabreëls FJM. 1994. Evidence for genetic heterogeneity underlying hereditary neuropathy with liability to pressure palsies. Hum Genet 93:151-156.
64. Marques W, Thomas PK, Sweeney MG, Carr L, Wood NW. 1998. Dejerine-Sottas neuropathy and PMP22 point mutations: a new base pair substitution and a possible "hot spot" on Ser72. Ann Neurol 43:680-683.
65. Marrosu MG, Vaccargiu S, Marrosu G, Vannelli A, Cianchetti C, Muntoni F. 1997. A novel point mutation in the peripheral myelin protein 22 (PMP22) gene associated with Charcot-Marie-Tooth disease type 1A. Neurology 48:489-493.
66. Marrosu MG, Vaccargiu S, Marrosu G, Vannelli A, Chianchetti C, Muntoni F. 1998. Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene. Neurology 50:1397-1401.
67. Martini R, Zielasek J, Toyka KV, Giese KP, Schachner M. 1995. Protein zero (P0)-deficient mice show myelin regeneration in peripheral nerves characteristic of inherited human neuropathies. Nature Genet 11:281-286.
68. Meggouh F, Benomar A, Rouger H, Tardieu S, Birouk N, Tassin J, Barhoumi C, Yahyaoui M, Chkili T, Brice A, LeGuern E. 1998. The first de novo mutation of the connexin 32 gene associated with X-linked Charcot-Marie-Tooth disease. J Med Genet 35:251-252.
69. Müller HW, Suter U, Van Broeckhoven C, Hanemann O, Nelis E, Timmerman V, Sancho S, Barrio LC, Bolhuis PA, Dermietzel R, Frank M, Gabreëls-Festen AAWM, Gillen C, Haites N, Levi G, Mariman ECM, Martini R, Nave KA, Rautenstrauss B, Schachner M, Schenone A, Schneider C, Schröder M, Willecke K. 1997. Advances in Charcot-Marie-Tooth disease research: cellular function of CMT-related proteins, transgenic animal models and pathomechanisms. Neurobiol Disease 4:215-220.
70. Navon R, Timmerman V, Löfgren A, Liang P, Nelis E, Zeitune M, Van Broeckhoven C. 1995. Prenatal diagnosis of Charcot-Marie-Tooth disease type 1A (CMT1A) using molecular genetic techniques. Prenatal diagnosis 15:633-640.
71. Navon R, Seifried B, Gal-On NS, Sadeh M. 1996. A new point mutation affecting the fourth transmembrane domain of PMP22 results in severe de novo Charcot-Marie-Tooth disease. Hum Genet 97:685-687.
72. Nelis E, Timmerman V, De Jonghe P, Van Broeckhoven C. 1994a. Identification of a 5′-splice site mutation in the PMP-22 gene in autosomal dominant Charcot-Marie-Tooth disease type 1. Hum Mol Genet 3:515-516.
73. Nelis E, Timmerman V, De Jonghe P, Muylle L, Martin J-J, Van Broeckhoven C. 1994b. Linkage and mutation analysis in an extended family with Charcot-Marie-Tooth disease type 1B. J Med Genet 31:811-815.
74. Nelis E, Timmerman V, De Jonghe P, Vandenberghe A, PhamDinh D, Dautigny A, Martin J-J, Van Broeckhoven C. 1994c. Rapid screening of myelin genes in CMT1 patients by SSCP analysis: identification of new mutations and polymorphisms in the P0 gene. Hum Genet 94:653-657.
75. Nelis E, Van Broeckhoven C, coauthors. 1996a. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hererditary neuropathy with liability to pressure palsies: a European collaborative study. Eur J Hum Genet 4:25-33.
76. Nelis E, Warner LE, De Vriendt E, Chance P, Lupski JR, Van Broeckhoven C. 1996b. Comparison of single-strand conformation polymorphism and heteroduplex analysis for detection of mutations in Charcot-Marie-Tooth type 1 disease and related peripheral neuropathies. Eur J Hum Genet 4:329-33.3.
77. Nelis E, Holmberg B, Adoltsson R, Holmgren G, Van Broeckhoven C. 1997a. PMP22 THr(118)Met: Recessive CMT1 mutation or polymorphism? Nature Genet 15:13-14.
78. Nelis E, Simokovic S, Timmerman V, Löfgren A, Backhovens H, De Jonghe P, Martin J-J, Van Broeckhoven C. 1997b. Mutation analysis of the connexin32 (Cx32) gene in Charcot-Marie-Tooth neuropathy type 1: identification of five new mutations. Hum Mutat 9:47-52.
79. Nelles E, Bützler C, Jung D, Temme A, Gabriel HD, Dahl U, Traub O, Stümpel F, Jungermann K, Zielasek J, Toyka KV, Dermietzel R, Willecke K. 1996. Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice. Proc Natl Acad Sci USA 93:9565-9570.
80. Neuhaus IM, Bone LJ, Wang S, Ionasescu VV, Werner R. 1996. The human connexin32 gene is transcribed from two tissue-specific promotors. Biosci Reports 16:239-248.
81. Nicholson G, Nash J. 1993. Intermediate nerve conduction velocities define X-linked Charcot-Marie-Tooth neuropathy families. Neurology 43:2558-2564.
82. Nicholson GA, Valentijn LJ, Cherryson AK, Kennerson ML, Bragg TL, De Kroon RM, Ross DA, Pollard JD, McLeod JD, Bolhuis PA, Baas F. 1994. A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies. Nature Genet 6:263-266.
83. Niewiadomski LA, Kelly TE. 1996. X-linked Charcot-Marie-Tooth disease: Molecular analysis of interfamilial variability. Am J Med Genet 66:175-178.
84. Oh S, Ri Y, Bennet MVL, Trexler EB, Verselis VK, Bargiello TA. 1997. Changes in permeability caused by connexin 32 mutations underlie X-linked Charcot-Marie-Tooth disease. Neuron 19:927-938.
85. Omori Y, Mesnil M, Yamasaki H. 1996. Connexin 32 mutations from X-linked Charcot-Marie-Tooth disease patients: functional defects and dominant negative effects. Mol Biol Cell 7:907-916.
86. Orth U, Fairweather N, Exler M-C, Schwinger E, Gal A. 1994. X-linked dominant Charcot-Marie-Tooth neuropathy: valine38-methionine substitution of connexin32. Hum Mol Genet 3:1699-1700.
87. Oterino A, Monton FI, Cabrera VM, Pinto F, Gonzalez A, Lavilla NR. 1996. Arginine-164-tryptophan substitution in connexin 32 associated with X linked dominant Charcot-Marie-Tooth disease. J Med Genet 33:413-415.
88. Palau F, Löfgren A, De Jonghe P, Bort S, Nelis E, Sevilla T, Martin J-J, Vílchez J, Prieto F, Van Broeckhoven C. 1993. Origin of the de novo duplication in Charcot-Marie-Tooth disease type 1A: unequal nonsister chromatid exchange during spermatogenesis. Hum Mol Genet 2:2031-2035.
89. Pareek S, Suter U, Snipes GJ, Welcher AA, Shooter EM, Murphy RA. 1993. Detection and processing of PMP22 in cultured Schwann cells. J Biol Chem 268:10372-10379.
90. Pareyson D, Botti S, Sghirlanzoni A, Taroni F. 1997. PMP22 frameshift mutation and hereditary neuropathy with liability to pressure palsies. Neurology 49:1478-1479.
91. Pentao L, Wise CA, Chinault AC, Patel PI, Lupski JR. 1992. Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit. Nature Genet 2:292-300.
92. Raeymaekers P, Timmerman V, Nelis E, De Jonghe P, Hoogendijk JE, Baas F, Barker DF, Martin J-J, de Visser M, Bolhuis PA, Van Broeckhoven C, HMSN Collaborative Research Group. 1991. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). Neuromusc Disord 1:93-97.
93. Raeymaekers P, Timmerman V, Nelis E, Van Hul W, De Jonghe P, Martin J-J, Van Broeckhoven C, HMSN Collaborative Research Group. 1992. Estimation of the size of the chromosome 17p11.2 duplication in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). J Med Genet 29:5-11.
94. Rautenstrauss B, Nelis E, Grehl H, Pfeiffer RA, Van Broeckhoven C. 1994. Identification of a de novo insertional mutation in P0 in a patient with a Déjérine-Sottas syndrome (DSS) phenotype. Hum Mol Genet 3:1701-1702.
95. Ressot C, Latour P, Blanquet-Grossard F, Sturtz F, Duthel S, Battin J, Corbillon E, Ollagnon E, Serville F, Vandenberghe A, Dautigny A, Pham-Dinh D. 1996. X-linked dominant Charcot-Marie-Tooth neuropathy (CMTX): New mutations in the connexin32 gene. Hum Genet 98:172-175.
96. Roa BB, Garcia CA, Pentao L, Killian JM, Trask BJ, Suter U, Snipes GJ, Ortiz-Lopez R, Shooter EM, Patel PI, Lupski JR. 1993a. Evidence for a recessive PMP22 point mutation in Charcot-Marie-Tooth disease type 1A. Nature Genet 5:189-194.
97. Roa BB, Dyck PJ, Marks HG, Chance PF, Lupski JR. 1993b. Dejerine-Sottas syndrome associated with point mutation in the PMP22 gene. Nature Genet 5:269-273.
98. Roa BB, Garcia CA, Suter U, Kulpa DA, Wise CA, Mueller J, Welcher AA, Snipes GJ, Shooter EM, Patel PI, Lupski JR. 1993c. Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene. N Engl J Med 329:96-101.
99. Roa BB, Warner LE, Garcia CA, Russo D, Lovelace R, Chance PF, Lupski JR. 1996. Myelin protein zero (MPZ) gene mutations in nondtiplication type 1 Charcot-Marie-Tooth disease. Hum Mutat 7:36-45.
100. Rouger H, LeGuern E, Gouider R, Tardieu S, Birouk N, Gugenheim M, Bouche P, Agid Y, Brice A. 1996. High frequency of mutations in codon 98 of the peripheral myelin protein P0 gene in 20 French CMT1 patients. Am J Hum Genet 58:638-641.
101. Rouger H, LeGuern E, Birouk N, Gouider R, Tardieu S, Plassart E, Gugenheim M, Vallat J-M, Louboutin J-P, Bouche P, Agid Y, Brice A. 1997. Charcot-Marie-Tooth disease with intermediate motor nerve conduction velocities: characterisation of 14 Cx32 mutations in 35 families. Hum Mutat 10:443-452.
102. Schiavon F, Fracasso C, Mostacciuolo ML. 1996. Novel missense mutation in the connexin32 (GJB1) gene in X-linked dominant Charcot-Marie-Tooth neuropathy. Hum Mutat 8:83-84.
103. Schiavon F, Rampazzo A, Merlini L, Angelini C, Mostacciuolo ML. 1998. Mutations of the same sequence of the myelin P0 gene causing two different phenotypes. Hum Mutat Suppl 1:S217-S219.
104. Senderek J, Bergmann C, Quasthoff S, Ramaekers VT, Schröder JM. 1998. X-linked dominant Charcot-Marie-Tooth disease: nerve biopsies allow morphological evaluation and detection of connexin32 mutations (Arg15Trp, Arg22Gln). Acta Neuropathol Berl 95:443-449.
105. Sereda M, Griffiths I, Pühlhofer A, Stewart H, Rossner MJ, Zimmermann F, Magyar JP, Schneider A, Hund E, Meinck H-M, Suter U, Nave K-A. 1996. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 16:1049-1060.
106. Sghirlanzoni A, Pareyson D, Balestrini MR, Bellone E, Berta E, Ciano C, Mandich P, Marazzi R. 1992. HMSN III phenotype due to homozygous expression of a dominant HMSN II gene. Neurology 42:2201-2203.
107. Silander K, Meretoja P, Nelis E, Timmerman V, Van Broeckhoven C, Aula P, Savontaus M-L. 1996. A de novo duplication in 17p11.2 and a novel mutation in the P0 gene in two Déjérine-Sottas syndrome patients. Hum Mutat 8:304-310.
108. Silandet K, Meretoja P, Pihko H, Juvonen V, Isskainen J, Aula P, Savontaus M-L. 1997. Screening for connexin 32 mutations in Charcot-Marie-Tooth disease families with possible X-linked inheritance. Hum Genet 100:391-397.
109. Silander K, Meretoja P, Juvonen V, Ignatius J, Pihko H, Saarinen A, Wallden T, Herregård E, Aula P, Savontaus M-L. 1998. Spectrum of mutations in Finnish patients with Charcot-Marie-Tooth disease and related neuropathies. Hum Mutat 12:59-68.
110. Sillén A, Annerén G, Dahl N. 1998. A novel mutation (C201R) in the transmembrane domain of connexin 32 in severe X-linked Charcot-Marie-Tooth disease. Hum Mutat Suppl 1:S8-S9.
111. Sorour E, MacMillan J, Upadhyaya M. 1997. Novel mutation of the myelin P0 gene in a CMT1B family. Hum Mutat 9:74-77.
112. Sorour E, Upadhyaya M. 1998. Mutation analysis in Charcot-Marie-Tooth disease type 1 (CMT1). Hum Mutat Suppl 1:S242-S247.
113. Suter U, Welcher AA, Özcelik T, Snipes G, Kosaras B, Francke U, Billings-Gagliardi S. 1992a. Trembler mouse carries a point mutation in a myelin gene. Nature 356:241-244.
114. Suter U, Moskow JJ, Welcher AA, Snipes G, Kosaras B, Sidman R, Buchberg A, Shooter E. 1992b. A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse. Proc Natl Acad Sci USA 89:4382-4386.
115. Suter U, Snipes J, Schoener-Scott R, Welcher AA, Pareek S, Lupski JR, Murphy RA, Shooter EM, Patel PI. 1994. Regulation of tissue-specific expression of alternative Peripheral Myelin Protein-22 (PMP22) gene transcripts by two promoters. J Biol Chem 269:25795-25808.
116. Tachi N, Kozuka N, Ohya K, Chiba S, Sasaki K, Uyemura K, Hayasaka K. 1996. A new mutation of the Po gene in patients with Charcot-Marie-Tooth disease type 1B: screening of the Po gene by heteroduplex analysis. Neurosci Lett 204:173-176.
117. Tachi N, Kozuka N, Ohya K, Chiba S, Yamashita S. 1998. A small direct tandem duplication of the myelin protein zero gene in patient with Dejerine-Sottas disease phenotype. J Neurol Sci 156:167-171.
118. Tan CC, Ainsworth PJ, Hahn AF, MacLeod PM. 1996. Novel mutations in the connexin 32 gene associated with X-linked Charcot-Marie-Tooth disease. Hum Mutat 7:161-171.
119. Timmerman V, Nelis E, Van Hu W, Nieuwenhuijsen BW, Chen KL, Wang S, Ben Othman K, Cullen B, Leach RJ, Hanemann CO, De Jonghe P, Raeymaekers P, van Ommen G-JB, Martin J-J, Müller HW, Vance JM, Fischbeck KH, Van Broeckhoven C. 1992. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nature Genet 1:171-175.
120. Timmerman V, De Jonghe P, Spoelders P, Simokovic S, Löfgren A, Nelis E, Vance J, Martin J-J, Van Broeckhoven C. 1996. Linkage and mutation analysis of Charcot-Marie-Tooth neuropathy type 2 families with chromosomes 1p35-p36 and Xq13. Neurology 46:1311-1318.
121. Tyson J, Ellis D, Fairbrother U, King RHM, Muntoni F, Jacobs K, Malcolm S, Harding AE, Thomas PK. 1997. Hereditary demyelinating neuropathy of infancy. A genetically complex syndrome. Brain 120:47-63.
122. Valentijn LJ, Baas F, Wolterman RA, Hoogendijk JE, van den Bosch NHA, Zorn I, Gabreëls-Festen AAWM, de Visser M, Bolhuis PA. 1992. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nature Genet 2:288-291.
123. Valentijn LJ, Ouvrier RA, van den Bosch NHA, Bolhuis PA, Baas F, Nicholson GA. 1995. Déjérine-Sottas neuropathy is associated with a de novo PMP22 mutation. Hum Mutat 5:76-80.
124. Vance JM, Nicholson GA, Yamaoka LH, Stajich J, Stewart JS, Speer MC, Hung W-J, Roses AD, Barker D, Pericak-Vance MA. 1989. Linkage of Charcot-Marie-Tooth neuropathy type 1a to chromosome 17. Exp Neurol 104:186-189.
125. 0) mutations may include Charcot-Marie-Tooth 1B, Dejerine-Sottas and congenital hypomyelination. Neuron 17:451-460.
126. 0) point mutations in a sporadic Dejerine-Sottas case. Hum Mutat 10:21-24.
127. Warner LE, Mancias P, Butler IJ, McDonald CM, Keppen L, Koob G, Lupski JR. 1998. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nature Genet 18:382-384.
128. Werner R, Levine E, Rabadan-Diehl C, Dahl G. 1991. Gating properties of connexin32 cell-cell channels and their mutants expressed in Xenopus oocytes. Proc R Soc Lond Biol 243:5-11.
129. Wicklein EM, Orth U, Gal A, Kunze K. 1997. Missense mutation (R15W) of the connexin32 gene in a family with X chromosomal Charcot-Marie-Tooth neuropathy with only female family members affected. J Neurol Neurosurg Psychiatry 63:379-381.
130. Windebank AJ. 1993. Inherited recurrent focal neuropathies. In: Dyck PJ, Thomas PK, Griffin JW, et al., editors. Peripheral neuropathy. Philadelphia: WB. Saunders Company. P 1137-1148.
131. Wolfe GI, Bryan WW, Barohn RJ. 1996. Clinical and molecular features of X-linked Charcot-Marie-Tooth disease. J Child Neurol 11:147.
132. Yoshikawa H, Nishimura T, Nakatsuji Y, Fujimura H, Mimoro M, Hayasaka K, Sakoda S, Yanagihara T. 1994. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A. Ann Neurol 35:445-450.
133. Yoshimura T, Ohnishi A, Yamamoto T, Fukushima Y, Kitani M, Kobayashi T. 1996. Two novel mutations (C53S, S26L) in the connexin32 of Charcot-Marie-Tooth disease type X families. Hum Mutat 8:270-272.
134. Young P, Wiebusch H, Stögbauer F, Ringelstein B, Assmann G, Funke H. 1997a. PMP22 frameshift mutation and hereditary neuropathy with liability to pressure palsies (reply). Neurology 49:1478-1479.
135. Young P, Wiebusch H, Stögbauer F, Ringelstein B, Assmann G, Funke H. 1997b. A novel frameshift mutation in PMP22 accounts for hereditary neuropathy with liability to pressure palsies. Neurology 48:450-452.